Viewing Study NCT00672295


Ignite Creation Date: 2025-12-24 @ 1:16 PM
Ignite Modification Date: 2026-01-25 @ 2:11 AM
Study NCT ID: NCT00672295
Status: COMPLETED
Last Update Posted: 2012-12-28
First Post: 2008-05-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: PH I SRC Kinase, Dasatinib Combo Paclitaxel & Carboplatin in Pts w Ovarian, Peritoneal, & Tubal Cancer
Sponsor: AA Secord
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ovarian Cancer View
None Peritoneal Cancer View
None Fallopian Tube Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Ovarian Cancer View
None Peritoneal Cancer View
None Tubal Cancer View
None Fallopian Tube Cancer View
None Dasatinib View
None Sprycel View
None Paclitaxel View
None Taxol View
None Carboplatin View
None Paraplatin View